GenOdyssee SA, Genopole Entreprises Company Profile

01:08 EST 10th December 2018 | BioPortfolio

GenOdyssee has an IP-protected product source that is unique in the industry. GenOdyssee pioneered the vision that natural evolution may have led to the generation in the current population of unpredictable mutations that confer superior or novel therapeutic status to known human therapeutic proteins. By utilizing high throughput analysis of natural genetic variation focused on genes coding for cytokines and cytokine receptors and pathways, GenOdyssee has identified a large number of naturally occurring variations of cytokines and growth factors.
GenOdyssee’s technology is protected by the international patent application PCT/EP03/13965 and is the sole property of the company. Such technology appears to be unique in the industry as demonstrated by a positive international examination report delivered by the EPO in 2005. The technology is applicable to a very broad range of proteins of potential use in human therapy across many disease areas and may provide a wealth of next-generation protein therapeutics.
Since 2001, because of the large and numerous possibilities of product applications from the approach invented by GenOdyssee, the company has been very aggressive in protecting in all major industrial territories its innovative discoveries sustained by its original identification procedure of "naturally optimised" therapeutic protein variants.


4 rue Pierre Fontaine


Phone: (+33) (0) 6 16 41 68 57
Fax: 33 (0) 1 60 87 89 99

News Articles [11 Associated News Articles listed on BioPortfolio]

European Business Awards: les secrets de l'incroyable succès des entreprises publiés aujourd'hui

LONDRES, December 8, 2018 /PRNewswire/ -- Une nouvelle collection d'études de cas des European Business Award se penche sur la réussite de certaines des entreprises Read more...

Hawksford acquiert l'un des principaux prestataires indépendants de services aux entreprises ...

     (Logo:      (Photo: P&P est une société dynamique ...

Genopole receives AURP Award of Excellence for Outstanding Research Park

The biocluster located in the Greater Paris region is the first European park to receive the Association of University Research Parks (AURP) award. Genopole, a French biocluster dedicated to rese...

La brochure complète de la conférence au sommet « OTC. ...

Le groupe des entreprises Nicholas Halla le plaisir d'annoncer qu'il comptera sur la présence, le 12 septembre à Londres, de prestigieux conférenciers venant Read more...

Rapport IARD: dans leur lutte contre la consommation nocive d'alcool, les grands producteurs de ...

LONDRES, August 10, 2018 /PRNewswire/ -- Les 11 entreprises produisant certaines des marques de bière, de vin et de spiritueux les plus populaires au monde Read more...

Soutenues par le Centre des exportations russes, des entreprises russes ont présenté de ...

Lors d'une exposition en Allemagne, des développeurs russes ont proposé une technique de récupération pour les patients ayant subi un AVC basée sur la réalité Read more...

Le Consumer Goods Forum lance la 5[e] édition de son enquête santé et bien-être

PARIS, July 25, 2018 /PRNewswire/ -- Les entreprises de biens de grande consommation feront le bilan des progrès accomplis en vue d'améliorer la santé des Read more...

French biocluster is accepting applications for the third intake of support programmes

French biocluster, Genopole, has announced it is accepting applications for the third intake of its support programmes — Shaker and Booster — to international applicants.

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Carmol hc [PharmaDerm A division of Nycomed US Inc.]

CARMOLHC(Hydrocortisone Acetate Cream USP, 1%)

PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [10 Associated Companies listed on BioPortfolio]

GenOdyssee SA, Genopole Entreprises

GenOdyssee has an IP-protected product source that is unique in the industry. GenOdyssee pioneered the vision that natural evolution may have led to the generation in the current population of unpredi...


Created in 1998 on the initiative of the French Government, local authorities and the Association Française contre les Myopathies, Genopole® is based on an original concept: bringing together academ...

Centre québécois d'innovation en biotechnologie

Le Centre québécois d'innovation en biotechnologie (CQIB), un organisme privé sans but lucratif fondé en 1995, est un incubateur d'entreprises spécialisé en biotechnologie. Accompagner, Innover,...


TEXCELL, a spin-off company of the Pasteur Institute, is based in Evry Genopole in more than 16,000 sq. ft of offices and BSL2/BSL3 laboratory facilities. TEXCELL offers GLP/GMP compliant services...


Nokad is a biotech start up created in January 2004 by three experienced scientists with scientific, medical, pharmaceutical and business skills. The head office and the laboratory are located at Geno...

More Information about "GenOdyssee SA, Genopole Entreprises" on BioPortfolio

We have published hundreds of GenOdyssee SA, Genopole Entreprises news stories on BioPortfolio along with dozens of GenOdyssee SA, Genopole Entreprises Clinical Trials and PubMed Articles about GenOdyssee SA, Genopole Entreprises for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of GenOdyssee SA, Genopole Entreprises Companies in our database. You can also find out about relevant GenOdyssee SA, Genopole Entreprises Drugs and Medications on this site too.

Quick Search


Relevant Topic

Cytokine Tumour Necrosis Factor (TNF)
TNF is a compound that is classified as a cytokine which plays a central role in the cellular mechanisms of apoptosis or cell death. However, there are a number of different kinds of TNF, just under twenty, but the family of molecules have very similar a...

Corporate Database Quicklinks

Searches Linking to this Company Record